Skip to main content
Erschienen in: Inflammation 5/2012

01.10.2012

Beneficial Effect of the Polysaccharides from Bupleurum smithii var. parvifolium on “Two-Hit” Acute Lung Injury in Rats

verfasst von: Xiao-Qin Cheng, Lu-Jin Song, Hong Li, Hongye Di, Yun-Yi Zhang, Dao-Feng Chen

Erschienen in: Inflammation | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

ABSTRACT

Radix Bupleuri is a traditional Chinese herb frequently used in the prescriptions for the treatment of inflammatory diseases. This study was to determine whether the crude polysaccharides isolated from the roots of Bupleurum smithii var. parvifolium (BPs) had beneficial effects on a “two-hit” acute lung injury model in rats. A two-hit lung injury model characterized by hemorrhagic shock followed by reperfusion and intratracheal lipopolysaccharide (1 mg kg−1) administration was established in Wistar rats. Drugs and saline were administered 30 min after the start of resuscitation. The two-hit acute lung injury model was successfully established. After oral administration, all BPs groups ameliorated pathological injury with lessened complement C3c deposit in lung. BPs 10 and 20 mg kg−1 diminished the ratio of wet-to-dry weight. In bronchoalveolar lavage (BAL) fluids, the protein concentration, the leukocytes counts, and the lung myeloperoxidase were significantly reduced. BPs also mediated the decreases in interleukin-6 and tumor necrosis factor-α in BAL fluids and in sera. Furthermore, BPs 20 mg kg−1 decreased the total complement hemolytic activity. BPs had beneficial effects on two-hit acute lung injury. The mechanisms of BPs on inflammatory disease might relate to its inhibitory effect on increased production of proinflammatory mediators and on overactivation of complement.
Literatur
1.
Zurück zum Zitat Chu, C.H., D.D. Liu, Y.H. Hsu, K.C. Lee, and H.I. Chen. 2007. Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats. Pulmonary Pharmacology and Therapeutics 20: 503–512.PubMedCrossRef Chu, C.H., D.D. Liu, Y.H. Hsu, K.C. Lee, and H.I. Chen. 2007. Propofol exerts protective effects on the acute lung injury induced by endotoxin in rats. Pulmonary Pharmacology and Therapeutics 20: 503–512.PubMedCrossRef
2.
Zurück zum Zitat Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.PubMedCrossRef Matthay, M.A., and G.A. Zimmerman. 2005. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. American Journal of Respiratory Cell and Molecular Biology 33: 319–327.PubMedCrossRef
3.
Zurück zum Zitat Yeh, C.C., C.C. Lin, S.D. Wang, Y.S. Chen, B.H. Su, and S.T. Kao. 2006. Protective and anti-inflammatory effect of a traditional Chinese medicine Xia-Bai-San, by modulating lung local cytokine in a murine model of acute lung injury. International Immunopharmacology 6: 1506–1514.PubMedCrossRef Yeh, C.C., C.C. Lin, S.D. Wang, Y.S. Chen, B.H. Su, and S.T. Kao. 2006. Protective and anti-inflammatory effect of a traditional Chinese medicine Xia-Bai-San, by modulating lung local cytokine in a murine model of acute lung injury. International Immunopharmacology 6: 1506–1514.PubMedCrossRef
4.
Zurück zum Zitat Jacob, H.S., P.R. Craddock, D.E. Hammerschmidt, and C.F. Moldow. 1980. Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. New England Journal of Medicine 302: 789–794.PubMedCrossRef Jacob, H.S., P.R. Craddock, D.E. Hammerschmidt, and C.F. Moldow. 1980. Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. New England Journal of Medicine 302: 789–794.PubMedCrossRef
5.
Zurück zum Zitat Hammerschmidt, D.E., L.J. Weaver, L.D. Hudson, P.R. Craddock, and H.S. Jacob. 1980. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet 1: 947–949.PubMedCrossRef Hammerschmidt, D.E., L.J. Weaver, L.D. Hudson, P.R. Craddock, and H.S. Jacob. 1980. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet 1: 947–949.PubMedCrossRef
6.
Zurück zum Zitat Weigelt, J.A., D.E. Chenoweth, K.R. Borman, and J.F. Norcross. 1988. Complement and the severity of pulmonary failure. The Journal of Trauma 28: 1013–1019.PubMedCrossRef Weigelt, J.A., D.E. Chenoweth, K.R. Borman, and J.F. Norcross. 1988. Complement and the severity of pulmonary failure. The Journal of Trauma 28: 1013–1019.PubMedCrossRef
7.
Zurück zum Zitat Hutchison, J. 2000. Neutrophils in sepsis, septic shock, and adult respiratory distress syndrome: how stiff is too stiff? Critical Care Medicine 28: 2659–2660.PubMedCrossRef Hutchison, J. 2000. Neutrophils in sepsis, septic shock, and adult respiratory distress syndrome: how stiff is too stiff? Critical Care Medicine 28: 2659–2660.PubMedCrossRef
8.
Zurück zum Zitat Zhao, R.Z., S.J. Liu, S.R. Mao, and Y.J. Wang. 2009. Study on liver targeting effect of vinegar-baked Radix Bupleuri on resveratrol in mice. Journal of Ethnopharmacology 126: 415–420.PubMedCrossRef Zhao, R.Z., S.J. Liu, S.R. Mao, and Y.J. Wang. 2009. Study on liver targeting effect of vinegar-baked Radix Bupleuri on resveratrol in mice. Journal of Ethnopharmacology 126: 415–420.PubMedCrossRef
9.
Zurück zum Zitat Ikegami, F., M. Sumino, Y. Fujii, T. Akiba, and T. Satoh. 2006. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Human & Experimental Toxicology 25: 481–494.CrossRef Ikegami, F., M. Sumino, Y. Fujii, T. Akiba, and T. Satoh. 2006. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Human & Experimental Toxicology 25: 481–494.CrossRef
10.
Zurück zum Zitat Wang, Z., H. Li, H. Xu, X.L. Yue, X.Q. Cheng, W.J. Hou, Y.Y. Zhang, and D.F. Chen. 2009. Beneficial effect of Bupleurum polysaccharides on autoimmune disease induced by Campylobacter jejuni in BALB/c mice. Journal of Ethnopharmacology 124: 481–487.PubMedCrossRef Wang, Z., H. Li, H. Xu, X.L. Yue, X.Q. Cheng, W.J. Hou, Y.Y. Zhang, and D.F. Chen. 2009. Beneficial effect of Bupleurum polysaccharides on autoimmune disease induced by Campylobacter jejuni in BALB/c mice. Journal of Ethnopharmacology 124: 481–487.PubMedCrossRef
11.
Zurück zum Zitat Cheng, X.Q., H. Li, X.L. Yue, J.Y. Xie, Y.Y. Zhang, H.Y. Di, and D.F. Chen. 2010. Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium. Journal of Ethnopharmacology 130: 363–368.PubMedCrossRef Cheng, X.Q., H. Li, X.L. Yue, J.Y. Xie, Y.Y. Zhang, H.Y. Di, and D.F. Chen. 2010. Macrophage immunomodulatory activity of the polysaccharides from the roots of Bupleurum smithii var. parvifolium. Journal of Ethnopharmacology 130: 363–368.PubMedCrossRef
12.
Zurück zum Zitat Xu, H., Y.Y. Zhang, J.W. Zhang, and D.F. Chen. 2007. Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii. International Immunopharmacology 7: 175–182.PubMedCrossRef Xu, H., Y.Y. Zhang, J.W. Zhang, and D.F. Chen. 2007. Isolation and characterization of an anti-complementary polysaccharide D3-S1 from the roots of Bupleurum smithii. International Immunopharmacology 7: 175–182.PubMedCrossRef
13.
Zurück zum Zitat Fan, J., J.C. Marshall, M. Jimenez, P.N. Shek, J. Zagorski, and O.D. Rotstein. 1998. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. Journal of Immunology 161: 440–447. Fan, J., J.C. Marshall, M. Jimenez, P.N. Shek, J. Zagorski, and O.D. Rotstein. 1998. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. Journal of Immunology 161: 440–447.
14.
Zurück zum Zitat Yoshinari, D., I. Takeyoshi, Y. Koibuchi, K. Matsumoto, Y. Kawashima, T. Koyama, S. Ohwada, and Y. Morishita. 2001. Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Critical Care Medicine 29: 628–634.PubMedCrossRef Yoshinari, D., I. Takeyoshi, Y. Koibuchi, K. Matsumoto, Y. Kawashima, T. Koyama, S. Ohwada, and Y. Morishita. 2001. Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Critical Care Medicine 29: 628–634.PubMedCrossRef
15.
Zurück zum Zitat Betsuyaku, T., J.M. Shipley, Z. Liu, and R.M. Senior. 1999. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. American Journal of Respiratory Cell and Molecular Biology 20: 1303–1309.PubMed Betsuyaku, T., J.M. Shipley, Z. Liu, and R.M. Senior. 1999. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. American Journal of Respiratory Cell and Molecular Biology 20: 1303–1309.PubMed
16.
Zurück zum Zitat Yoko, I., B. Tomoko, N. Katsura, N. Yasuyuki, and N. Masaharu. 2005. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Experimental Gerontology 40: 315–323.CrossRef Yoko, I., B. Tomoko, N. Katsura, N. Yasuyuki, and N. Masaharu. 2005. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Experimental Gerontology 40: 315–323.CrossRef
17.
Zurück zum Zitat Nahum, A., A. Adina, M. Eliau, R. Ishay, D. Shlomit, and K. Tamar. 2009. Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. Toxicology and Applied Pharmacology 241: 154–162.CrossRef Nahum, A., A. Adina, M. Eliau, R. Ishay, D. Shlomit, and K. Tamar. 2009. Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries. Toxicology and Applied Pharmacology 241: 154–162.CrossRef
18.
Zurück zum Zitat Moore, F.A., and E.E. Moore. 1995. Evolving concepts in the pathogenesis of postinjury multiple organ failure. The Surgical Clinics of North America 75: 257–277.PubMed Moore, F.A., and E.E. Moore. 1995. Evolving concepts in the pathogenesis of postinjury multiple organ failure. The Surgical Clinics of North America 75: 257–277.PubMed
19.
Zurück zum Zitat Zhang, H., and G.Y. Sun. 2005. LPS induces permeability injury in lung microvascular endothelium via AT1 receptor. Archives of Biochemistry and Biophysics 441: 75–83.PubMedCrossRef Zhang, H., and G.Y. Sun. 2005. LPS induces permeability injury in lung microvascular endothelium via AT1 receptor. Archives of Biochemistry and Biophysics 441: 75–83.PubMedCrossRef
20.
Zurück zum Zitat Lang, J.D., and J.M. Hickman-Davis. 2005. One-hit, two-hit…is there really any benefit? Clinical and Experimental Immunology 141: 211–214.PubMedCrossRef Lang, J.D., and J.M. Hickman-Davis. 2005. One-hit, two-hit…is there really any benefit? Clinical and Experimental Immunology 141: 211–214.PubMedCrossRef
21.
Zurück zum Zitat Rotstein, O.D. 2003. Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. The Journal of Trauma 54: 203–206.CrossRef Rotstein, O.D. 2003. Modeling the two-hit hypothesis for evaluating strategies to prevent organ injury after shock/resuscitation. The Journal of Trauma 54: 203–206.CrossRef
22.
Zurück zum Zitat Tamandl, D., M. Bahrami, B. Wessner, G. Weigel, M. Ploder, W. Furst, E. Roth, G. Boltz-Nitulescu, and A. Spittler. 2003. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 20: 224–229.PubMedCrossRef Tamandl, D., M. Bahrami, B. Wessner, G. Weigel, M. Ploder, W. Furst, E. Roth, G. Boltz-Nitulescu, and A. Spittler. 2003. Modulation of toll-like receptor 4 expression on human monocytes by tumor necrosis factor and interleukin-6: tumor necrosis factor evokes lipopolysaccharide hyporesponsiveness, whereas interleukin-6 enhances lipopolysaccharide activity. Shock 20: 224–229.PubMedCrossRef
23.
Zurück zum Zitat Rocco, P.R.M., D.P. Momesso, R.C. Figueira, H.C. Ferreira, R.A. Cadete, A. Legora-Machado, V.L.G. Koatz, L.M. Lima, E.J. Barreiro, and W.A. Zin. 2003. Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury. European Respiratory Journal 22: 20–27.PubMedCrossRef Rocco, P.R.M., D.P. Momesso, R.C. Figueira, H.C. Ferreira, R.A. Cadete, A. Legora-Machado, V.L.G. Koatz, L.M. Lima, E.J. Barreiro, and W.A. Zin. 2003. Therapeutic potential of a new phosphodiesterase inhibitor in acute lung injury. European Respiratory Journal 22: 20–27.PubMedCrossRef
24.
Zurück zum Zitat Niwa, M., A. Hara, Y. Kanamori, D. Hatakeyama, M. Saio, T. Takami, H. Matsuno, O. Kozawa, and T. Uematsu. 2000. Nuclear factor-kappaB activates dual inhibition sites in the regulation of tumor necrosis factor-alpha-induced neutrophil apoptosis. European Journal of Pharmacology 407: 211–219.PubMedCrossRef Niwa, M., A. Hara, Y. Kanamori, D. Hatakeyama, M. Saio, T. Takami, H. Matsuno, O. Kozawa, and T. Uematsu. 2000. Nuclear factor-kappaB activates dual inhibition sites in the regulation of tumor necrosis factor-alpha-induced neutrophil apoptosis. European Journal of Pharmacology 407: 211–219.PubMedCrossRef
25.
Zurück zum Zitat Michael, T.G., B. Karim, J.C. Mitchell, A.S. Lisa, C.W. Mary, L.S. Gregory, and P. Jean-Francois. 2007. Role of the alternative pathway in the early complement activation following major trauma. Shock 28: 29–34.CrossRef Michael, T.G., B. Karim, J.C. Mitchell, A.S. Lisa, C.W. Mary, L.S. Gregory, and P. Jean-Francois. 2007. Role of the alternative pathway in the early complement activation following major trauma. Shock 28: 29–34.CrossRef
26.
Zurück zum Zitat Guo, R.F., and P.A. Ward. 2005. Role of C5a in inflammatory responses. Annual Review of Immunology 23: 821–852.PubMedCrossRef Guo, R.F., and P.A. Ward. 2005. Role of C5a in inflammatory responses. Annual Review of Immunology 23: 821–852.PubMedCrossRef
27.
Zurück zum Zitat Drouin, S.M., J. Kildsgaard, J. Haviland, J. Zabner, H.P. Jia, P.B.J. McCray, B.F. Tack, and R.A. Wetsel. 2001. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. Journal of Immunology 166: 2025–2032.PubMed Drouin, S.M., J. Kildsgaard, J. Haviland, J. Zabner, H.P. Jia, P.B.J. McCray, B.F. Tack, and R.A. Wetsel. 2001. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. Journal of Immunology 166: 2025–2032.PubMed
28.
Zurück zum Zitat Ward, P.A. 1996. Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury. The American Journal of Pathology 149: 1081–1086.PubMed Ward, P.A. 1996. Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury. The American Journal of Pathology 149: 1081–1086.PubMed
29.
Zurück zum Zitat Gustavo, M.B., W.F. Charles, and R.M. Thomas. 2008. Animal models of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 295: 379–399.CrossRef Gustavo, M.B., W.F. Charles, and R.M. Thomas. 2008. Animal models of acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 295: 379–399.CrossRef
Metadaten
Titel
Beneficial Effect of the Polysaccharides from Bupleurum smithii var. parvifolium on “Two-Hit” Acute Lung Injury in Rats
verfasst von
Xiao-Qin Cheng
Lu-Jin Song
Hong Li
Hongye Di
Yun-Yi Zhang
Dao-Feng Chen
Publikationsdatum
01.10.2012
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 5/2012
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9489-7

Weitere Artikel der Ausgabe 5/2012

Inflammation 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.